Molecular Templates, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Balance Sheet Components (Tables)

Balance Sheet Components (Tables)

12 Months Ended

Dec. 31, 2017

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Components of Accrued Liabilities

Accrued liabilities comprise the following (in thousands):

		December 31,
		2017				2016
Accrued liabilities:
General and administrative		$	374			$	26
Clinical costs			702				409
Non-clinical research			435				2
Bridge note interest			—				201
Payroll related			1,149				553
Other accrued expenses			30				19
Total accrued liabilities		$	2,690			$	1,210

Components of Deferred Revenue

Deferred revenue was comprised of the following:

		December 31,
		2017				2016
Deferred revenue
Grant agreements		$	1,673			$	620
Collaboration agreements			1,092				1,250
Total deferred revenue		$	2,765			$	1,870